PATENT CLAIM ANALYSIS

Application Number: 15776927
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "404000"]

Abstract:
The disclosure generally relates to a therapeutic approach based on the stimulation of resolution of inflammation by the Formyl-Peptide Receptor 2/Lipoxin A 4  receptor (FPR2/ALX) for the treatment of heart disease.

Claim (Index 2):
The method of  claim 1  wherein the heart disease is selected from the group consisting of angina pectoris, unstable angina, myocardial infarction, heart failure, acute coronary disease, acute heart failure, chronic heart failure, and cardiac iatrogenic damage.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.13333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13681496', '15656766', '14196047', '15490127', '14905768']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7818227683148571
- 35 USC 102 Novelty (BERT): 0.5158306246075234
- Combined Prediction Score: 0.7552235539441237
- Mean Citation Score: 187.28120400000003
- Max Citation Score: 217.76012000000003
- Similarity Product: 111.82337260752205

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test